Onimusha: Way of the Sword and The Blood of Dawnwalker Both Cross 1 Million Sales
Capcom and Rebel Wolves have both started September with major commercial milestones, as Onimusha: Way of the Sword and The Blood of Dawnwalker have each surpassed 1 million copies sold worldwide only days after release. The results are particularly significant because one represents the return of a dormant Capcom franchise after 20 years, while the other establishes a completely new dark fantasy RPG intellectual property from a relatively young studio.
Capcom confirmed that Onimusha: Way of the Sword surpassed 1 million worldwide sales on its launch day following its September 4 release across PlayStation 5, Xbox Series X and Series S, Nintendo Switch 2, and PC. The result also pushed lifetime sales for the entire Onimusha franchise beyond 10 million units. It represents an important early validation of Capcom's decision to revive the series after struggling for years to assemble a development team, a challenge previously examined when looking at why Capcom could not assemble an Onimusha team for 20 years.
The launch follows several encouraging indicators ahead of release. Onimusha: Way of the Sword won Best Gameplay and Best Sony PlayStation Game at Gamescom 2026, while its playable demo previously surpassed 1 million downloads. Capcom also moved the game's release forward from September 25 to September 4, giving it more separation from a crowded late September gaming schedule. That decision now appears particularly well timed, with the first day sales giving the revived franchise considerable momentum immediately after launch. AMD has also been supporting the PC release through an ongoing Onimusha bundle with selected Ryzen 9000 processors and Radeon RX 9000 graphics cards.
The Blood of Dawnwalker has reached the same 1 million sales threshold from a very different position. Rebel Wolves confirmed the milestone on September 5 after the game launched on September 3 for PC, PlayStation 5, and Xbox Series X and Series S. The developer has not provided a detailed platform breakdown, but reaching 1 million copies within its opening days is a substantial result for Rebel Wolves' first commercial release and for a new intellectual property competing without decades of established brand recognition. Bandai Namco's official launch announcement describes the game as the first chapter of an original saga, suggesting the publisher and developer have broader plans for its world beyond this initial release.
Rebel Wolves was founded by veterans of CD Projekt RED and has built The Blood of Dawnwalker around a choice driven dark fantasy structure where Coen exists between humanity and vampirism. We previously explored how the game allows players to approach its story without a traditional main quest structure, while Rebel Wolves has also emphasized that player decisions can significantly alter characters, quests, and outcomes throughout its approximately 70 hour experience. That unconventional design appears to have found an audience quickly, giving the studio an unusually strong opening for its debut project.
The 2 games reaching the same milestone also highlights very different paths toward commercial success. Onimusha entered the market with a recognizable Capcom name, established history, major promotional support, and an audience that had been waiting 20 years for a new entry. The Blood of Dawnwalker instead had to establish its characters, world, systems, and identity almost entirely from scratch. For both to pass 1 million units this early suggests strong demand for premium single player action and role playing experiences even as publishers increasingly compete for player time through live service models.
The most interesting part of these milestones is not simply that both games sold 1 million copies. It is what each result represents. Onimusha proves that Capcom can reactivate another legacy franchise without relying exclusively on Resident Evil, Monster Hunter, and Street Fighter, while The Blood of Dawnwalker demonstrates that a new studio with experienced developers can still establish an original premium RPG at significant scale. If both games maintain momentum beyond their launch windows, September 2026 could become an important case study for publishers considering investments in dormant franchises and ambitious new single player intellectual properties.
Which success is more impressive to you, Onimusha returning with 1 million sales on its first day, or The Blood of Dawnwalker reaching the same milestone as a completely new franchise?
